Showing 911-920 of 1655 results for "".
- Men’s skincare market expected to grow by more than $6Bhttps://modernaesthetics.com/news/mens-skincare-market-expected-grow-more-than-6-billion/2473585/Skincare products targeted for men are generating massive attention and new market research estimates the market will grow by more than $6 billion over the next four years. Technavio reports a CAGR of about 7.19% from 2024 to 2028. Industry leaders are catering to t
- Elevai Labs Eyes Obesity Treatment Market with Myostatin Inhibitorshttps://modernaesthetics.com/news/elevai-labs-expands-pipeline-eyes-obesity-treatment-market-with-myostatin-inhibitors/2473568/Elevai Labs, Inc. announced that it has acquired exclusive rights to two assets (EL-22 and EL-32) aimed at preventing muscle loss and treating obesity, according to a company press release. The new assets, according to the company, involve engineered probiotics expressing myostatin and
- Murad Alam, MD, FAAD, Elected American Academy of Dermatology President for 2026https://modernaesthetics.com/news/murad-alam-md-faad-elected-american-academy-of-dermatology-president-for-2026/2473558/Chicago-based board-certified dermatologist Murad Alam, MD, FAAD, has been elected to lead the American Academy of Dermatology (AAD). He will be installed as president-elect in March 2025 and hold the office of president for 1 year beginning in March 2026. AAD is the world’s large
- Allergan Aesthetics Launches Program to Elevate the Conversation Around Ethics in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-launches-program-to-elevate-the-conversation-around-ethics-in-aesthetics/2473556/Allergan Aesthetics announced the launch of 'Moving the Needle on Ethics,' a collaboration with medical aesthetics experts from around the globe aimed at elevating discussions on ethics in aesthetics. The collection of interviews is designed to highlight the
- Cutera Launches AviClear for the Treatment of Acne in UK, Europe and Australiahttps://modernaesthetics.com/news/cutera-launches-aviclear-for-the-treatment-of-acne-in-uk-europe-and-australia/2473548/Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, a
- Eucerin Introduces First Face Care Collection With Multi-Weight Hyaluronic Acid Technologyhttps://modernaesthetics.com/news/eucerin-introduces-first-face-care-collection-with-multi-weight-hyaluronic-acid-technology/2473544/Hitting shelves January 2024, Eucerin's Immersive Hydration Collection is a new entry into the face-care category with a unique, multi-weight hyaluronic acid formulation. A first to pioneer this technology across a full face care regimen* to intensively hydrate skin and visibly smoo
- Exosome X Mitochondrial Technology: Elevai Labs Enters Into Licensing Agreement With Yuva Bioscienceshttps://modernaesthetics.com/news/exosome-x-mitochondrial-technologies-elevai-labs-enters-into-licensing-agreement-with-yuva-biosciences/2473536/Elevai Labs, Inc. signed a licensing agreement with Yuva Biosciences, Inc. to research and develop means to incorporate Yuva Bioscience’s mitochondrial research with ELEVAI’s PREx (Precision Regenerative Exosome Technology) in topical skincare. The potential collab could com
- Exosome Update: ELEVAI Labs Announces Pricing of $6,000,000 IPOhttps://modernaesthetics.com/news/exosome-update-elevai-labs-announces-pricing-of-6000000-ipo/2473530/Elevai Labs, Inc. announced the pricing of its initial public offering. The Offering consists of 1,500,000 shares of common stock at a public offering price of $4.00 per share, for total gross proceeds of $6,000,000 before deducting underwriting discounts and o
- AestheticsWire Exclusive: Embracing Diversity in Aestheticshttps://modernaesthetics.com/news/embracing-diversity-in-aesthetics/2473528/There’s no such thing as a one-size-fits-all approach to rejuvenation as people across genders, ethnicities, and age groups often have different concerns and aesthetic goals. This is the main takeaway from a new study that sought to better understand facial and body aesthetic conc
- Revance Taps Erica Jordan as CCOhttps://modernaesthetics.com/news/revance-taps-erica-jordan-as-coo/2473522/Erica Jordan is now Revance Therapeutics, Inc.’s Chief Commercial Officer (CCO), Aesthetics. “Given the importance of the DAXXIFY launch, I’m excited to elevate Erica to the position of Chief Commercial Officer, Aesthetics reporting directly to me. Having wo